We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Proteome Sciences Plc | PRM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.50 | 08:00:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.50 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 18/4/2024 16:09 by 049balt If there is even a sniff of value in any of prm patents then the share will explode. |
Posted at 12/4/2024 16:51 by elpirata I note that cjp's loan with interest accruing is now £11.235m & prm has an mcap just over £9m |
Posted at 10/4/2024 14:45 by wasjobber Unfortunately, you should pay far more attention, as your hatred for everything PRM completely blinds you. Proteome Sciences have stated AD license deals publicly. You can find out where yourself.STRONG BUY |
Posted at 10/4/2024 12:43 by elpirata the olde fishing expedition bait given another outing I note our patented biomarkers may prove critical in development of novel diagnostic tests opening up additional licensing opportunitiesAs of April 2024, there are at least eight different Alzheimer’s blood biomarker tests on the market... & prm nowhere to be seen, we've been down this alleged patents rabbit hole many times before |
Posted at 10/4/2024 10:02 by pools2 wasjobber,Thermo have been a long term partner of Proteome Sciences for 15 years, but I agree it'll be good to see Thermo taking a more prominent position. After reading the RNS this morning, the future looks brighter than ever. You've already mentioned what I think is probably the most significant RNS statement:- "It's very interesting that PRM are now openly stating that their patented Alzheimer's and cancer biomarkers may be critical to new diagnostics and treatment moving forward. STRONG BUY" It's very significant for Proteome Sciences to say that. The value of these biomarkers will be considerable and will project PRM into the £100 millions plus market cap. with ease. I think you are now correct, we are at a pivotal moment for the share price and investors buying now will achieve significant returns, possibly quicker than some may think. |
Posted at 10/4/2024 09:15 by wasjobber It looks like Thermo are getting more involved with PRM."We continue to innovate in chemistry and will be working on ancillary products to add new functionality for TMTproTM enabled studies through a sponsored research project." |
Posted at 10/4/2024 08:28 by wasjobber It's very interesting that PRM are now openly stating that their patented Alzheimer's and cancer biomarkers may be critical to new diagnostics and treatment moving forward.STRONG BUY |
Posted at 05/4/2024 07:25 by peverill Are pools and wasjobber one and the same.They have a knack of both putting 2+2 together to make 5.Where anywhere does it say the NHS are using PRM markers in these trials,Given PRM's precarious position you would think they would be shouting from the rooftops if true. |
Posted at 28/3/2024 15:12 by barry evans PramBigear 3 Jul '06 - 20:11 - 38468 of 61525 0 0 0Give it a rest Goatherd! "However I find Peter's theories and posts far more likely than yours. You sit on the fence and bleat. He posts what he believes - it is simply up to his readers what they do. It is possible that you will cost posters vastly more than Peter ever will." Jeffian's logical posts are certainly as valid as "Peter's theories" and certainly could not COST posters more than Peter's ever will, for Jeffian's implicit message is "don't risk your cash" whilst Peter's is "fill yer boots". You can only lose money that you already have. Miss an opportunity, perhaps, but that is not a COST. jeffian3 Jul '06 - 22:59 - 38472 of 61525 0 0 0 Richard, As Pram points out, a potential profit foregone is not exactly the same as a loss! When Peter said on 27/1/04 "we can be sure that the value of PRM shares will soon far exceed the £8 that Tuco forecast in his recent post" and encouraged people to buy, the share price was around 215. If it fulfilled Peter's best expectations tomorrow by 5-bagging without any opportunity to buy on the way up....then people who took his advice then would just about break even while followers of the Bar Room Monkey tendency would be in the same boat. I call that even-stevens. If, on the other hand, Peter's best expectations are not met, some people out there are nursing a nasty loss. That also presupposes that there will be no opportunity to climb aboard when/if it becomes clear that the potential is being turned into £££ but this flies in the face of the evidence of most major long-term growth stories from Microsoft downwards as a glimpse at their share charts will show. To take your point of a 'potential' £53 valuation over time, other than how stinking rich you want to be, it doesn't matter much whether you climb aboard at 39, 45, 60, £1 or £2, you're still going to do OK. Obviously my approach is more risk-averse but it concerns me that Peter's posts, however honestly held his views, go beyond just presenting his argument to stating that it is only our own stupidity which prevents us from drawing the same conclusions and specifically encouraging people to buy - and they have. As you say, "it is simply up to his readers what they do" but it doesn't hurt to remind them of the alternatives. Having made a bit of money, I like 'not losing it' almost as much as making more! In a wider context, as ever PRM-ers are following parallel (but not necessarily convergent!) courses with those of a 'scientific' bent hanging on the perceived progress of the IP while the BRM's want evidence to back up the claims - made by the company itself since 2003 remember - that it can be converted into a highly cash-generative asset. I have seen this so may times with shares like SPS, NTX, TRK, GHT etc. which have all had flurries of excitement having unique technology which should have given them access to vast markets but they've overpromised and underdelivered and the City won't rate them until the £££'s roll in. It's the same with this one and, whilst you may not like me saying it, a glance at the chart shows that if I'm 'wrong' I'm not alone so I may be some use to you contra-cyclical types to show you how the wider market is thinking! Finally, Richard, in your obsession with traders/shorters, you tend to see everything in terms of 'Buy' or 'Sell' but there is a perfectly respectable position called 'Hold', which is what I've been doing since Feb 2000. Or "sitting on the fence" as you call it. Regards, Ian |
Posted at 07/3/2024 18:40 by wrighty41 The current CEO of PRM is proving herself to be uninspiring imo.I’m still hopeful we may see 6p+ on the share price this year but without any update from PRM on the forward looking revenue outlook for 2024 it’s difficult to say. We’ll get the FY results over next couple of months. The forward guidance will be critical for share price progress. W41 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
